Prudential Financial Inc. Cuts Stock Holdings in CME Group Inc. (NASDAQ:CME)

Prudential Financial Inc. lowered its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 12.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 195,585 shares of the financial services provider’s stock after selling 28,388 shares during the quarter. Prudential Financial Inc.’s holdings in CME Group were worth $45,421,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of CME Group by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock worth $7,952,273,000 after purchasing an additional 326,623 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after buying an additional 142,692 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of CME Group during the fourth quarter worth $871,063,000. Janus Henderson Group PLC raised its position in shares of CME Group by 17.8% in the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after buying an additional 380,071 shares during the last quarter. Finally, Capital Wealth Planning LLC lifted its stake in shares of CME Group by 69.2% in the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after buying an additional 996,498 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Royal Bank of Canada upped their price objective on shares of CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research note on Thursday, February 13th. Erste Group Bank upgraded CME Group to a “strong-buy” rating in a research report on Monday, March 17th. Barclays lifted their price objective on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Keefe, Bruyette & Woods upped their target price on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Finally, Morgan Stanley lifted their price target on CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $238.93.

Read Our Latest Stock Report on CME Group

Insider Activity

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. This represents a 12.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares in the company, valued at $5,453,085.45. This represents a 34.63 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Down 0.3 %

CME Group stock opened at $262.06 on Wednesday. The company has a market capitalization of $94.44 billion, a PE ratio of 27.10, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $267.91. The firm has a 50 day moving average price of $247.77 and a 200 day moving average price of $234.95.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.91%. The ex-dividend date is Friday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio is currently 51.71%.

CME Group announced that its board has authorized a share buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.